Index by Author

January/February 2014; Volume 68,Issue 1

  1. Blumel, J.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  2. Blumel, Johannes

    1. Viral Safety Perspective from the Paul-Ehrlich-Institut in Europe
      Johannes Blümel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 11-12; DOI: https://doi.org/10.5731/pdajpst.2014.00960

  3. Brorson, K.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  4. Brorson, Kurt

    1. Role of Risk Assessments in Viral Safety: An FDA Perspective
      Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959
    2. Proceedings of the 2011 Viral Clearance Symposium (South San Francisco, CA)
      Kurt Brorson and Rich Levy
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 1; DOI: https://doi.org/10.5731/pdajpst.2014.00957
    3. Overview of 2009 Indianapolis Conference White Paper: The Goal of an Integrated Viral Clearance Strategy
      Kurt Brorson
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 2-5; DOI: https://doi.org/10.5731/pdajpst.2014.00958
Back to top

In This Issue